Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1 1

Status

Completed 6Unknown 3Withdrawn 2Terminated 2Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Sigmoidal Tumour 1Pain, Postoperative 1Erector Spinae Block Analgesia 1

Interventions

Cisplatin 509Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 329Paclitaxel 325Oxaliplatin 324Gemcitabine 319Docetaxel 311Fluorouracil 284Drug Therapy 244apatinib 242Bevacizumab 230camrelizumab 214Etoposide 200Irinotecan 177Doxorubicin 175Leucovorin 162Dexamethasone 160sintilimab 142pembrolizumab 140anlotinib 136Pemetrexed 136Cytarabine 136toripalimab 129Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 117Radiosurgery 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Interventional × Levobupivacaine × Clear all
NCT03979599 2023-04-19

Safety and Efficacy of Magnesium Sulphate as an Adjuvant to Levobupivacaine in Ultra-sound Guided Transversus Abdominis Plan Block in Pediatric Abdominal Cancer Surgery

South Egypt Cancer Institute

Phase 3 Unknown
10 enrolled

Pain, Postoperative

NCT04315454 2020-03-19

Aalgesic Efficacy of Erector -Spinae Technique With Levobupvicaine in Patients Undergoing Upper Abdominal Cancer Surgery

South Egypt Cancer Institute

Phase 1 Unknown
30 enrolled

Erector Spinae Block Analgesia

NCT01825993 2013-04-08

2013/004

Corporacion Parc Tauli

Phase 3 Unknown
225 enrolled

Sigmoidal Tumour

Data powered by HemOnc (CC BY 4.0) Colophon âš¡